‘Unusually Cautious’: Biotech Dealmakers Hit the Brakes
After a quiet period for biotech M&A, dealmakers started 2025 with renewed optimism. Many expected a rebound in billion-dollar transactions, bolstered by early momentum like Johnson & Johnson’s $14.6 billion acquisition of neuroscience biotech Intra-Cellular Therapies, announced in January. Enthusiasm has since faded, with political instability and market swings cooling appetites and deepening the divide […]
EV Market Outpaces Hybrids with a 29% YTD surge
EV sales are accelerating globally, with China and the EU driving most of the momentum. While geopolitical tensions persist, policy shifts and domestic incentives are pushing the industry forward, though North America remains a weak spot.
German 
English